GAIA-123

N/A

Report date: 2022/05/10 11:42:09

Base Information

Drug NameGAIA-123
Drug Alias NameGAIA123
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyCell and gene therapy > Cell therapy
Mechanisms of ActionImmunologic cytotoxicityCell replacements
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGaia BioMedicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesGaia BioMedicine Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A